Abbvie Inc. vs IQVIA Holdings Inc.
ABBV vs IQV — side-by-side comparison from reported financials. ABBV leads 6, IQV leads 5 of 11 comparable metrics.
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
IQVIA Holdings Inc.
IQV · Healthcare
$259.88+0.39%Strained
| Metric | ABBV | IQV |
|---|---|---|
| Price | $276.43 | $259.88 |
| Market cap | $488B | $42.8B |
| Revenue (TTM) | $64.4B | $17.0B |
| Revenue growth | +1.8% | +4.2% |
| Net margin | 9.8% | 8.1% |
| Free cash flow | $18.2B | $2.18B |
| Net cash (debt) | ($56.2B) | ($11.7B) |
| 1-year price return | +19.8% | +28.0% |
| P/E | 77.4 | 31.1 |
| P/E vs own history (cheap-side %) | 23% | 56% |
| Dividend yield | 2.45% | — |
| Return on equity | 96% | 22% |
| Altman Z-score | 2.33 | 1.78 |
| CV checks passed | 9 of 11 | 8 of 11 |
| Employees | 57,000 | 94,000 |
Full résumé-style profiles: ABBV CV · IQV CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.